The insurer had spent over $300 million on GLP-1 medications, with projections showing costs approaching $1 billion by 2026 if trends continued
Mounjaro is designed specifically for type 2 diabetes, while Zepbound is intended for chronic weight management
In practice, that means a higher risk of severe nausea, vomiting, and GI distress than you had when starting either drug on its own
Retatrutide affects three receptors: GLP-1, GIP, and glucagon, making it highly effective for people who need broader metabolic support
Myofibroblasts are the primary producers of collagen in tissue fibrosis 67,68 and play a role in tissue stiffness and the development of skin and joint contractures in SSc patients
Constipation and GLP-1 Medications: What You Need to Know Before Symptoms Start Constipation is a common but often overlooked side effect in people taking GLP-1 receptor agonists, a class of medications widely used to treat obesity and type 2 diabetes